63 related articles for article (PubMed ID: 9990816)
1. [Eradication of Helicobacter pylori in peptic ulcer patients].
Buzás GM; Székely E
Orv Hetil; 1999 Jan; 140(3):121-4. PubMed ID: 9990816
[TBL] [Abstract][Full Text] [Related]
2. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M; Székely E; Illyés G; Széles I
Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
4. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
Hsu CC; Lu SN; Changchien CS
Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
[TBL] [Abstract][Full Text] [Related]
5. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
[TBL] [Abstract][Full Text] [Related]
7. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Tam YH; Yeung CK; Lee KH
Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
[TBL] [Abstract][Full Text] [Related]
8. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
Vakil N; Cutler A
Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
[TBL] [Abstract][Full Text] [Related]
9. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
10. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
[TBL] [Abstract][Full Text] [Related]
12. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
13. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
[TBL] [Abstract][Full Text] [Related]
14. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
15. [Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori].
Flores S; Opazo H; Valderrama D; Aguilera R; Marchese A; Valderrama S
Rev Med Chil; 2000 May; 128(5):509-12. PubMed ID: 11008354
[TBL] [Abstract][Full Text] [Related]
16. [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Multiple Center Study Group In Beijing Area, China
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1161-5. PubMed ID: 15387976
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
[TBL] [Abstract][Full Text] [Related]
18. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM
Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099
[TBL] [Abstract][Full Text] [Related]
19. A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection.
Hsieh YH; Lin HJ; Tseng GY; Perng CL; Chang FY; Lee SD
Hepatogastroenterology; 2001; 48(40):1078-81. PubMed ID: 11490804
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
